Brokerages Set Bath & Body Works, Inc. (NYSE:BBWI) Target Price at $43.19

Bath & Body Works, Inc. (NYSE:BBWI - Get Free Report) has earned an average recommendation of "Moderate Buy" from the seventeen research firms that are presently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, six have given a hold rating and ten have assigned a buy rating to the company. The average twelve-month price target among analysts that have covered the stock in the last year is $43.19.

BBWI has been the subject of several research reports. Piper Sandler increased their price target on shares of Bath & Body Works from $36.00 to $39.00 and gave the company a "neutral" rating in a research report on Monday, January 6th. Wells Fargo & Company upgraded shares of Bath & Body Works from an "equal weight" rating to an "overweight" rating and raised their price target for the stock from $42.00 to $48.00 in a research note on Friday, January 10th. Morgan Stanley dropped their price objective on Bath & Body Works from $51.00 to $48.00 and set an "overweight" rating on the stock in a research note on Thursday, November 21st. Argus reissued a "hold" rating on shares of Bath & Body Works in a research report on Friday, January 10th. Finally, Telsey Advisory Group reaffirmed an "outperform" rating and set a $42.00 price target on shares of Bath & Body Works in a research report on Monday, November 25th.

Bath & Body Works Stock Down 1.1 %

NYSE:BBWI traded down $0.41 during trading hours on Friday, hitting $35.48. 3,468,221 shares of the company traded hands, compared to its average volume of 2,990,789. Bath & Body Works has a one year low of $26.20 and a one year high of $52.99. The firm's 50-day simple moving average is $37.71 and its 200-day simple moving average is $33.65. The company has a market cap of $7.68 billion, a PE ratio of 8.65, a PEG ratio of 0.90 and a beta of 1.83.

Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its quarterly earnings results on Monday, November 25th. The company reported $0.49 EPS for the quarter, topping analysts' consensus estimates of $0.46 by $0.03. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The business had revenue of $1.61 billion for the quarter, compared to analyst estimates of $1.58 billion. During the same period last year, the company posted $0.48 earnings per share. Bath & Body Works's quarterly revenue was up 3.1% compared to the same quarter last year. As a group, equities research analysts expect that Bath & Body Works will post 3.26 EPS for the current year.

Bath & Body Works Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, March 7th. Stockholders of record on Friday, February 21st will be issued a $0.20 dividend. The ex-dividend date of this dividend is Friday, February 21st. This represents a $0.80 annualized dividend and a dividend yield of 2.25%. Bath & Body Works's payout ratio is currently 19.51%.

Institutional Investors Weigh In On Bath & Body Works

Large investors have recently added to or reduced their stakes in the business. SRS Capital Advisors Inc. increased its stake in Bath & Body Works by 99.7% in the 4th quarter. SRS Capital Advisors Inc. now owns 659 shares of the company's stock worth $26,000 after acquiring an additional 329 shares during the last quarter. Golden State Wealth Management LLC bought a new position in shares of Bath & Body Works in the fourth quarter worth approximately $26,000. UMB Bank n.a. raised its stake in Bath & Body Works by 58.8% in the fourth quarter. UMB Bank n.a. now owns 905 shares of the company's stock valued at $35,000 after purchasing an additional 335 shares in the last quarter. Lindbrook Capital LLC lifted its position in Bath & Body Works by 81.9% during the fourth quarter. Lindbrook Capital LLC now owns 957 shares of the company's stock valued at $37,000 after purchasing an additional 431 shares during the last quarter. Finally, Smartleaf Asset Management LLC grew its stake in Bath & Body Works by 135.0% in the 4th quarter. Smartleaf Asset Management LLC now owns 1,013 shares of the company's stock worth $39,000 after buying an additional 582 shares in the last quarter. Institutional investors own 95.14% of the company's stock.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.